TP53 and Alzheimer disease: Consequently, we have demonstrated that following DDR induction fibroblasts, NSCs and neurons from AD patients displayed activation of the ATM/ATR signalling, manifested by recruitment and activation of ATM, but not ATR, and downstream effector Chk2 kinase, and ultimately mobilization of the p53 protein (Wezyk et al. 2018).